Eli Lilly's Phase 3 study highlights the effectiveness of Orforglipron in lowering blood sugar and promoting weight loss, ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

US-based pharmaceutical company Eli Lilly on Thursday announced that its experimental oral GLP-1 pill, named orforglipron, ...

The weight loss increased to 12.2 pounds for those taking 6-milligram doses and 16 pounds ... could be readily manufactured and launched at scale for use by people around the world." ...

In this week’s edition of InnovationRx, we look at the impact of Medicaid cuts, a $400 million obesity bet, a study of bias ...

The bumblebee-inspired robot is less than a centimeter wide and can hover, change direction, and hit small targets. Like a ...

Eli Lilly said on Thursday its experimental pill, orforglipron, led to weight loss of nearly 8% at the highest dose and ...

April 17 (UPI) --People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug ... manufactured and launched at scale for use by people around the ...

Eli Lilly & Co.'s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

A civil society group and several academics in Chiang Rai and Chiang Mai have issued an urgent letter to Prime Minister Paetongtarn Shinawatra, demanding government intervention to address severe ...